It is reasonable to take both observations seriously as hypotheses, with two cautions: Phase 2 trials are smaller, and the trial populations are not identical to GLP-1 trial populations
Most people experienced no issue after taking the injections, but side effects are possible, particularly if the administration isnt handled by a certified professional
"Ro's direct-to-patient model helps patients achieve outcomes on par with clinical trials and have the best experiences, all at the lowest available prices for FDA-approved treatments." Ro's obesity care formulary is one the most comprehensive of any telehealth company, integrating cash pay and insurance-eligible options that can be delivered to one's home or picked up at a retail pharmacy
[25] James WPT, Caterson ID, Coutinho W, et al
Case Scenario to Guide Second-Line Treatment Selection A 52-year-old man with a three-year history of T2DM presents for a review